Melanoma prevention strategy based on using tetrapeptide α‐MSH analogs that protect human melanocytes from UV‐induced DNA damage and cytotoxicity
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Melanoma is the deadliest form of skin cancer, with no cure for advanced disease. We propose a strategy for melanoma prevention based on using analogs of α‐melanocyte stimulating hormone (α‐MSH) that function as melanocortin 1 receptor (MC1R) agonists. Treatment of human melanocytes with α‐MSH results in stimulation of eumelanin synthesis, reduction of apoptosis that is attributable to reduced hydrogen peroxide generation and enhanced repair of DNA photoproducts. These effects should contribute to genomic stability of human melanocytes, thus preventing their malignant transformation to melanoma. Based on these findings, we synthesized and tested the effects of 3 tetrapeptide α‐MSH analogs, Ac‐His‐D‐Phe‐Arg‐Trp‐NH 2 , n‐Pentadecanoyl‐ and 4‐Phenylbutyryl‐His‐D‐Phe‐Arg‐Trp‐NH2, on cultured human melanocytes. The latter two analogs were more potent than the former, or α‐MSH, in stimulating the activity of tyrosinase, thus melanogenesis, reducing apoptosis and release of hydrogen peroxide and enhancing repair of DNA photoproducts in melanocytes exposed to UV radiation (UVR). The above analogs are MC1R agonists, as their effects were abrogated by an analog of agouti signaling protein, the physiological MC1R antagonist, and were absent in melanocytes expressing loss‐of‐function MC1R. Analogs, such as 4‐Phenylbutyryl‐His‐D‐Phe‐Arg‐Trp‐NH 2 with prolonged and reversible effects, can potentially be developed into topical agents to prevent skin photocarcinogenesis, particularly melanoma.—Abdel‐Malek, Z. A., Kadekaro, A. L., Kavanagh, R. J., Todorovic, A., Koikov, L. N., McNulty, J. C., Jackson, P. J., Millhauser, G. L., Schwemberger, S., Babcock, G., Haskell‐Luevano, C., Knittel, J. J. Melanoma prevention strategy based on using tetrapeptide α‐MSH analogs that protect human melanocytes from UV‐induced DNA damage and cytotoxicity. FASEB J. 20, E888–E896 (2006)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Besides defective pigmentary responses (D’Orazio et al., 2006; Spry et al., 2009) and dysregulated AKT signaling (Cao et al., 2013), our data support the concept that MC1R-signaling defective individuals are melanoma-prone because of blunted cAMP signaling and inadequate genome maintenance (Abdel-Malek et al., 2006; Dong et al., 2010; Kadekaro et al., 2012).”
From RETRACTED: PKA-Mediated Phosphorylation of ATR Promotes Recruitment of XPA to UV-Induced DNA Damage (2014) · cites this paper as Abdel-Malek et al., 2006
In the citing paper
“Mediated by robust cAMP second messenger generation, MC1R signaling enhances the rate of clearance of UV-induced DNA photodamage (Abdel-Malek et al., 2006; Dong et al., 2010; Kadekaro et al., 2012).”
From RETRACTED: PKA-Mediated Phosphorylation of ATR Promotes Recruitment of XPA to UV-Induced DNA Damage (2014) · cites this paper as Abdel-Malek et al., 2006
In the citing paper
“To date, several studies have indicated that α-MSH might reduce UV-induced skin damage via alternative mechanisms (1, 3, 6–8).”
From Melanocyte-stimulating hormone directly enhances UV-Induced DNA repair in keratinocytes by a xeroderma pigmentosum group A-dependent mechanism (2010) · cites this paper as [6]
In the citing paper
“On the other hand, the Abdel-Malek group has demonstrated that α-MSH can prevent UV-induced DNA damage and apoptosis in melanocytes (1, 3, 6–8).”
From Melanocyte-stimulating hormone directly enhances UV-Induced DNA repair in keratinocytes by a xeroderma pigmentosum group A-dependent mechanism (2010) · cites this paper as [6]
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674 · cited 1×
“This potential preventive strategy should benefit most individuals with a high risk for melanoma, particularly those heterozygous for melanoma-associated MC1R alleles, or expressing mutations in other melanoma susceptibility genes, such as p16 or BRAF (26, 40 ).”
BackgroundKrude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., & Grüters, A. (1998) · Nature Genetics · doi:10.1038/509 · Cited by 1,733
The cloning of a family of genes that encode the melanocortin receptors
Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., & Cone, R. D. (1992) · Science · doi:10.1126/science.1325670 · Cited by 1,635 · cited 2×
“The effects of melanocortins on human melanocytes are mediated by binding and activating the MC1R, a Gs protein-coupled receptor with seven transmembrane domains (13).”
BackgroundMethodAgouti protein is an antagonist of the melanocyte-stimulating-hormone receptor
Lu, D., Willard, D., Patel, I. R., Kadwell, S., Overton, L., Kost, T., Luther, M., Chen, W., Woychik, R. P., Wilkison, W. O., et al. (1994) · Nature · doi:10.1038/371799a0 · Cited by 1,076
Palmer, J. S., Duffy, D. L., Box, N. F., Aitken, J. F., O'Gorman, L. E., Green, A. C., Hayward, N. K., Martin, N. G., & Sturm, R. A. (2000) · The American Journal of Human Genetics · doi:10.1086/302711 · Cited by 503 · cited 3×
“The importance of melanocortins and the MC1R in melanoma prevention is underscored by the compelling evidence that loss-of-function mutations in the MC1R are associated with increased risk for melanoma ( 26 ).”
BackgroundInfluentialRole of oxidative stress and the antioxidant network in cutaneous carcinogenesis
Sander, C. S., Chang, H., Hamm, F., Elsner, P., & Thiele, J. J. (2004) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2004.02222.x · Cited by 438
The Pigmentary System: Physiology and Pathophysiology
Hsin-Su, Y. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.4.478 · Cited by 429
Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides
Abdel-Malek, Z., Swope, V. B., Suzuki, I., Akcali, C., Harriger, M. D., Boyce, S. T., Urabe, K., & Hearing, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1789 · Cited by 377
Self-citationSuzuki, I. (1996) · Endocrinology · doi:10.1210/en.137.5.1627 · Cited by 333
Self-citationChakraborty, A. K., Funasaka, Y., Slominski, A., Ermak, G., Hwang, J., Pawelek, J. M., & Ichihashi, M. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(96)00063-8 · Cited by 333
Research works printed but not linked: 4
- American Cancer Society, 2005, Facts and Figures
- Abdel-Malek Z., 1998, The Pigmentary System. Physiologyand Pathophysiology, 115
- Hadley M. E., 1996, Endocrinology
- 10.1210/endo.137.5.8612494 · DOI · Paper page
Cited by
D'Orazio, J., Jarrett, S., Amaro-Ortiz, A., & Scott, T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140612222 · Cited by 1,984
“The melanocortin 1 receptor (MC1R) is a critical genetic locus involved in pigmentation, the adaptive tanning response and skin cancer susceptibility [185–192].”
BackgroundPhotoageing: mechanism, prevention and therapy
Yaar, M., & Gilchrest, B. A. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08108.x · Cited by 755
Brzoska, T., Luger, T. A., Maaser, C., Abels, C., & Böhm, M. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0027 · Cited by 323
Melanocortin 1 Receptor: Structure, Function, and Regulation
Wolf Horrell, E. M., Boulanger, M. C., & D’Orazio, J. A. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00095 · Cited by 272
Ultraviolet Radiations: Skin Defense-Damage Mechanism
Mohania, D., Chandel, S., Kumar, P., Verma, V., Digvijay, K., Tripathi, D., Choudhury, K., Mitten, S. K., & Shah, D. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-56017-5_7 · Cited by 262
Metadata
- Authors
- Abdel-Malek, Z. A., Kadekaro, A. L., Kavanagh, R. J., Todorovic, A., Koikov, L. N., Mcnulty, J. C., Jackson, P. J., Millhauser, G. L., Schwemberger, S., Babcock, G., Haskell-Luevano, C., Knittel, J. J., Abdel-Malek, Z. A., Kadekaro, A. L., Kavanagh, R. J., Todorovic, A., Koikov, L. N., Mcnulty, J. C., Jackson, P. J., Millhauser, G. L., Schwemberger, S., Babcock, G., Haskell-Luevano, C., & Knittel, J. J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2006-05-24
- Volume
- 20
- Issue
- 9
- Pages
- 1561-1563
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2103633212
- Cited by
- 71
- References
- 39
- Citations by year
- 2024: 2 · 2023: 3 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 4 · 2015: 2 · 2014: 5 · 2013: 5 · 2012: 3
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R01 ES-09110, DK 064265, DK 57080)
- University of Cincinnati
- Johnson and Johnson
- American Heart Association
- Skin Cancer Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Dermatology › Skin Protection and Aging
- Keywords
- melanoma prevention, human melanocytes, UV-induced DNA damage, hydrogen peroxide, apoptosis, tyrosinase, ASIP, topical agents, genome stability
- MeSH terms
- alpha-MSH, DNA Damage, Humans, Melanocytes, Melanoma, Oligopeptides, Peptide Fragments, Skin Neoplasms, Ultraviolet Rays, Anticarcinogenic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Melanoma prevention strategy based on using tetrapeptide α‐MSH analogs that protect human melanocytes from UV‐induced DNA damage and cytotoxicity. https://app.cochat.ai/papers/10.1096/fj.05-5655fje
- The paper
- Abdel-Malek, Z. A., Kadekaro, A. L., Kavanagh, R. J., Todorovic, A., Koikov, L. N., Mcnulty, J. C., Jackson, P. J., Millhauser, G. L., Schwemberger, S., Babcock, G., Haskell-Luevano, C., Knittel, J. J., Abdel-Malek, Z. A., Kadekaro, A. L., Kavanagh, R. J., Todorovic, A., Koikov, L. N., Mcnulty, J. C., Jackson, P. J., . . . Knittel, J. J. (2006). Melanoma prevention strategy based on using tetrapeptide α‐MSH analogs that protect human melanocytes from UV‐induced DNA damage and cytotoxicity. The FASEB Journal. https://doi.org/10.1096/fj.05-5655fje
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.